Predictors and long-term patterns of medication adherence to glaucoma treatment in Denmark—an observational registry study of 30100 Danish patients with glaucoma

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Predictors and long-term patterns of medication adherence to glaucoma treatment in Denmark—an observational registry study of 30100 Danish patients with glaucoma. / Kolko, Miriam; Hansen, Rikke Faergemann; Dal, Louise G.; Sabelström, Emma; Brandel, Magnus; Bentsen, Andreas Hoiberg; Falch-Joergensen, Anne Cathrine.

In: BMJ Open Ophthalmology, Vol. 9, No. 1, e001607, 2024.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Kolko, M, Hansen, RF, Dal, LG, Sabelström, E, Brandel, M, Bentsen, AH & Falch-Joergensen, AC 2024, 'Predictors and long-term patterns of medication adherence to glaucoma treatment in Denmark—an observational registry study of 30100 Danish patients with glaucoma', BMJ Open Ophthalmology, vol. 9, no. 1, e001607. https://doi.org/10.1136/bmjophth-2023-001607

APA

Kolko, M., Hansen, R. F., Dal, L. G., Sabelström, E., Brandel, M., Bentsen, A. H., & Falch-Joergensen, A. C. (2024). Predictors and long-term patterns of medication adherence to glaucoma treatment in Denmark—an observational registry study of 30100 Danish patients with glaucoma. BMJ Open Ophthalmology, 9(1), [e001607]. https://doi.org/10.1136/bmjophth-2023-001607

Vancouver

Kolko M, Hansen RF, Dal LG, Sabelström E, Brandel M, Bentsen AH et al. Predictors and long-term patterns of medication adherence to glaucoma treatment in Denmark—an observational registry study of 30100 Danish patients with glaucoma. BMJ Open Ophthalmology. 2024;9(1). e001607. https://doi.org/10.1136/bmjophth-2023-001607

Author

Kolko, Miriam ; Hansen, Rikke Faergemann ; Dal, Louise G. ; Sabelström, Emma ; Brandel, Magnus ; Bentsen, Andreas Hoiberg ; Falch-Joergensen, Anne Cathrine. / Predictors and long-term patterns of medication adherence to glaucoma treatment in Denmark—an observational registry study of 30100 Danish patients with glaucoma. In: BMJ Open Ophthalmology. 2024 ; Vol. 9, No. 1.

Bibtex

@article{ddc3e2b82c0b4374b44d9b19c577609c,
title = "Predictors and long-term patterns of medication adherence to glaucoma treatment in Denmark—an observational registry study of 30100 Danish patients with glaucoma",
abstract = "Background Self-treatment with glaucoma medication (eye drops) has been associated with adherence challenges. Poor adherence results in worse outcomes in terms of visual field loss. Objective To investigate patterns in medication adherence among Danish patients with glaucoma in relation to selected predictors of adherence, long-term adherence patterns, and long-term societal economic consequences of poor adherence. Methods and analysis This register-based study included 30 100 glaucoma patients followed for 10 years between 2000 and 2018. Glaucoma was identified from the Danish national registers by diagnosis of Open Angle Glaucoma and/or by redeemed prescriptions of glaucoma medication. Logistic regression models were applied to estimate patient characteristics related to medical adherence. Diagnosis-related group fees were applied to estimate healthcare costs. Results High adherence in the first year(s) of treatment was less likely among men (ORfirst year: 0.78, 95% CI: 0.75 to 0.82), younger individuals and among those with a positive Charlson Comorbidity Index (CCI) score (ORfirst year/CCI≥3: 0.71, 95% CI: 0.63 to 0.80). Adherence in the first year and in the first two years was associated with adherence in the fifth (ORfirst year: 4.55, 95% CI: 4.30 to 4.82/ORfirst two years: 6.47, 95% CI: 6.10 to 6.86) as with adherence in the 10th year with slightly lower estimates. Being medical adherent was related to higher costs related to glaucoma medication after 5 and 10 years comparing with poor adherence, whereas poor adherence was associated with a marked increase in long-term costs for hospital contacts. Conclusion Increasing age, female sex and low comorbidity score are correlated with better adherence to glaucoma treatment. Adherence in the first years of treatment may be a good predictor for future adherence. In the long term, patients with poor adherence are overall more expensive to society in terms of hospital contacts.",
author = "Miriam Kolko and Hansen, {Rikke Faergemann} and Dal, {Louise G.} and Emma Sabelstr{\"o}m and Magnus Brandel and Bentsen, {Andreas Hoiberg} and Falch-Joergensen, {Anne Cathrine}",
note = "Publisher Copyright: {\textcopyright} Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.",
year = "2024",
doi = "10.1136/bmjophth-2023-001607",
language = "English",
volume = "9",
journal = "BMJ Open Ophthalmology",
issn = "2397-3269",
publisher = "BMJ Publishing Group",
number = "1",

}

RIS

TY - JOUR

T1 - Predictors and long-term patterns of medication adherence to glaucoma treatment in Denmark—an observational registry study of 30100 Danish patients with glaucoma

AU - Kolko, Miriam

AU - Hansen, Rikke Faergemann

AU - Dal, Louise G.

AU - Sabelström, Emma

AU - Brandel, Magnus

AU - Bentsen, Andreas Hoiberg

AU - Falch-Joergensen, Anne Cathrine

N1 - Publisher Copyright: © Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

PY - 2024

Y1 - 2024

N2 - Background Self-treatment with glaucoma medication (eye drops) has been associated with adherence challenges. Poor adherence results in worse outcomes in terms of visual field loss. Objective To investigate patterns in medication adherence among Danish patients with glaucoma in relation to selected predictors of adherence, long-term adherence patterns, and long-term societal economic consequences of poor adherence. Methods and analysis This register-based study included 30 100 glaucoma patients followed for 10 years between 2000 and 2018. Glaucoma was identified from the Danish national registers by diagnosis of Open Angle Glaucoma and/or by redeemed prescriptions of glaucoma medication. Logistic regression models were applied to estimate patient characteristics related to medical adherence. Diagnosis-related group fees were applied to estimate healthcare costs. Results High adherence in the first year(s) of treatment was less likely among men (ORfirst year: 0.78, 95% CI: 0.75 to 0.82), younger individuals and among those with a positive Charlson Comorbidity Index (CCI) score (ORfirst year/CCI≥3: 0.71, 95% CI: 0.63 to 0.80). Adherence in the first year and in the first two years was associated with adherence in the fifth (ORfirst year: 4.55, 95% CI: 4.30 to 4.82/ORfirst two years: 6.47, 95% CI: 6.10 to 6.86) as with adherence in the 10th year with slightly lower estimates. Being medical adherent was related to higher costs related to glaucoma medication after 5 and 10 years comparing with poor adherence, whereas poor adherence was associated with a marked increase in long-term costs for hospital contacts. Conclusion Increasing age, female sex and low comorbidity score are correlated with better adherence to glaucoma treatment. Adherence in the first years of treatment may be a good predictor for future adherence. In the long term, patients with poor adherence are overall more expensive to society in terms of hospital contacts.

AB - Background Self-treatment with glaucoma medication (eye drops) has been associated with adherence challenges. Poor adherence results in worse outcomes in terms of visual field loss. Objective To investigate patterns in medication adherence among Danish patients with glaucoma in relation to selected predictors of adherence, long-term adherence patterns, and long-term societal economic consequences of poor adherence. Methods and analysis This register-based study included 30 100 glaucoma patients followed for 10 years between 2000 and 2018. Glaucoma was identified from the Danish national registers by diagnosis of Open Angle Glaucoma and/or by redeemed prescriptions of glaucoma medication. Logistic regression models were applied to estimate patient characteristics related to medical adherence. Diagnosis-related group fees were applied to estimate healthcare costs. Results High adherence in the first year(s) of treatment was less likely among men (ORfirst year: 0.78, 95% CI: 0.75 to 0.82), younger individuals and among those with a positive Charlson Comorbidity Index (CCI) score (ORfirst year/CCI≥3: 0.71, 95% CI: 0.63 to 0.80). Adherence in the first year and in the first two years was associated with adherence in the fifth (ORfirst year: 4.55, 95% CI: 4.30 to 4.82/ORfirst two years: 6.47, 95% CI: 6.10 to 6.86) as with adherence in the 10th year with slightly lower estimates. Being medical adherent was related to higher costs related to glaucoma medication after 5 and 10 years comparing with poor adherence, whereas poor adherence was associated with a marked increase in long-term costs for hospital contacts. Conclusion Increasing age, female sex and low comorbidity score are correlated with better adherence to glaucoma treatment. Adherence in the first years of treatment may be a good predictor for future adherence. In the long term, patients with poor adherence are overall more expensive to society in terms of hospital contacts.

U2 - 10.1136/bmjophth-2023-001607

DO - 10.1136/bmjophth-2023-001607

M3 - Journal article

C2 - 38626933

AN - SCOPUS:85190902957

VL - 9

JO - BMJ Open Ophthalmology

JF - BMJ Open Ophthalmology

SN - 2397-3269

IS - 1

M1 - e001607

ER -

ID: 390521131